Frontiers in Medicine | Nuclear Medicine

Original Research

Published on 08 Feb 2023

Radiation safety considerations for the use of radium-224-calciumcarbonate-microparticles in patients with peritoneal metastasis

in Nuclear Medicine

Simen Rykkje Grønningsæter
Johan Blakkisrud
Silje Selboe
Mona-Elisabeth Revheim
Øyvind Sverre Bruland
Tina Bjørnlund Bønsdorff
Stein Gunnar Larsen
Caroline Stokke

Frontiers in Medicine

doi 10.3389/fmed.2023.1058914

3,813 views
2 citations

Original Research

Published on 03 Feb 2023

Fast myocardial perfusion SPECT denoising using an attention-guided generative adversarial network

in Nuclear Medicine

Jingzhang Sun
Bang-Hung Yang
Chien-Ying Li
Yu Du
Yi-Hwa Liu
Tung-Hsin Wu
Greta S. P. Mok

Frontiers in Medicine

doi 10.3389/fmed.2023.1083413

3,146 views
6 citations

Original Research

Published on 02 Feb 2023

Skeletal standardized uptake values obtained using quantitative SPECT/CT for the detection of bone metastases in patients with lung adenocarcinoma

in Nuclear Medicine

Lin Lin
Rong Zheng
Jianhua Geng
Xuejuan Wang
Meng Li
Rong Fan
Yiqing Zheng
Ke Yang

Frontiers in Medicine

doi 10.3389/fmed.2023.1119214

4,154 views
6 citations

Review

Published on 02 Feb 2023

Commercial and business aspects of alpha radioligand therapeutics

in Nuclear Medicine

Emanuele Ostuni
Martin R. G. Taylor

Frontiers in Medicine

doi 10.3389/fmed.2022.1070497

15,767 views
20 citations

Review

Published on 26 Jan 2023

Standardized classification schemes in reporting oncologic PET/CT

in Nuclear Medicine

Vanessa Murad
Roshini Kulanthaivelu
Claudia Ortega
Patrick Veit-Haibach
Ur Metser

Frontiers in Medicine

doi 10.3389/fmed.2022.1051309

6,791 views
3 citations

Editorial

Published on 23 Jan 2023

Editorial: Development of selective carbon-11 radioligands for target-based PET molecular imaging in oncology, cardiology and neurology

in Nuclear Medicine

Sridhar Goud Nerella
Manoj Kumar
Kiran Kumar Solingapuram Sai
Chander Singh Digwal

Frontiers in Medicine

doi 10.3389/fmed.2023.1137088

1,240 views

Original Research

Published on 19 Jan 2023

Influence of key histological characteristics on 18F-fluorodeoxyglucose /18F-choline positron emission tomography positivity in hepatocellular carcinoma: A machine learning study

in Nuclear Medicine

Jérôme Ghidaglia
Vincent Laurent
Mylène Sebagh
Alina Pascale
Emmanuel Durand
Nicolas Golse
Florent L. Besson

Frontiers in Medicine

doi 10.3389/fmed.2023.1087957

1,792 views
3 citations

Mini Review

Published on 19 Jan 2023

18-Fluorodeoxyglucose positron emission tomography/computed tomography for large vessel vasculitis in clinical practice

in Nuclear Medicine

Kladoum Nassarmadji
Anthony Vanjak
Venceslas Bourdin
Karine Champion
Ruxandra Burlacu
Stéphane Mouly
Damien Sène
Cloé Comarmond

Frontiers in Medicine

doi 10.3389/fmed.2023.1103752

2,314 views
5 citations

Original Research

Published on 19 Jan 2023

MRI-derived radiomics to guide post-operative management of glioblastoma: Implication for personalized radiation treatment volume delineation

in Nuclear Medicine

S. Chiesa
R. Russo
F. Beghella Bartoli
I. Palumbo
G. Sabatino
M. C. Cannatà
R. Gigli
S. Longo
H. E. Tran
L. Boldrini

Frontiers in Medicine

doi 10.3389/fmed.2023.1059712

2,273 views
3 citations

Hypothesis and Theory

Published on 17 Jan 2023

Dual targeting with 224Ra/212Pb-conjugates for targeted alpha therapy of disseminated cancers: A conceptual approach

in Nuclear Medicine

Asta Juzeniene
Vilde Yuli Stenberg
Øyvind Sverre Bruland
Mona-Elisabeth Revheim
Roy Hartvig Larsen

Frontiers in Medicine

doi 10.3389/fmed.2022.1051825

5,252 views
10 citations

Mini Review

Published on 09 Jan 2023

Targeted thorium-227 conjugates as treatment options in oncology

in Nuclear Medicine

Jenny Karlsson
Christoph A. Schatz
Antje M. Wengner
Stefanie Hammer
Arne Scholz
Alan Cuthbertson
Volker Wagner
Hartwig Hennekes
Vicki Jardine
Urs B. Hagemann

Frontiers in Medicine

doi 10.3389/fmed.2022.1071086

7,166 views
20 citations

Review

Published on 06 Jan 2023

Astatine-211 based radionuclide therapy: Current clinical trial landscape

in Nuclear Medicine

Per Albertsson
Tom Bäck
Karin Bergmark
Andreas Hallqvist
Mia Johansson
Emma Aneheim
Sture Lindegren
Chiara Timperanza
Knut Smerud
Stig Palm

Frontiers in Medicine

doi 10.3389/fmed.2022.1076210

22,263 views
49 citations

Original Research

Published on 05 Jan 2023

Performance characteristics of 18F–fluorodeoxyglucose in non-infected hip replacement

in Nuclear Medicine

Yiqun Wang
Lulu Yuan
Yinqiao Du
Honghong Liu
Qingxiao Li
Yan Chang
Yuanyuan Shi
Yanmei Wang
Xiaolin Meng
Yonggang Zhou

Frontiers in Medicine

doi 10.3389/fmed.2022.1043812

3,291 views

Brief Research Report

Published on 04 Jan 2023

Clinical imaging of primary pulmonary nucleoprotein of the testis carcinoma

in Nuclear Medicine

Wenpeng Huang
Yongbai Zhang
Qi Yang
Ge Gao
Yongkang Qiu
Liming Li
Lei Kang

Frontiers in Medicine

doi 10.3389/fmed.2022.1083206

1,765 views
2 citations

Review

Published on 04 Jan 2023

Comparing absorbed doses and radiation risk of the α-emitting bone-seekers [223Ra]RaCl2 and [224Ra]RaCl2

in Nuclear Medicine

Michael Lassmann
Uta Eberlein

Frontiers in Medicine

doi 10.3389/fmed.2022.1057373

4,985 views
5 citations

Mini Review

Published on 22 Dec 2022

Real-world effectiveness, long-term safety and treatment pathway integration of radium-223 therapy in patients with metastatic castration-resistant prostate cancer

in Nuclear Medicine

Joe M. O’Sullivan
Rana R. McKay
Kambiz Rahbar
Karim Fizazi
Daniel J. George
Bertrand Tombal
Anja Schmall
Per Sandström
Frank Verholen
Neal Shore

Frontiers in Medicine

doi 10.3389/fmed.2022.1070392

6,387 views
8 citations